
HemeTalks: Conversations in Hematology Education
by American Society of Hematology
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 28 chart positions in 28 markets.
By chart position
- 🇦🇺AU · Courses#6630K to 100K
- 🇺🇸US · Courses#7230K to 100K
- 🇸🇪SE · Courses#3630K to 100K
- 🇯🇵JP · Courses#5610K to 30K
- 🇪🇸ES · Courses#1391K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
132K to 442K🎙 ~2x weekly·32 episodes·Last published 6d ago - Monthly Reach
Unique listeners across all episodes (30 days)
264K to 884K🇦🇺11%🇺🇸11%🇸🇪11%+25 more - Active Followers
Loyal subscribers who consistently listen
106K to 354K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHost
Recent guests
Recent episodes
Unfolding Amyloid: A Patient Perspective
Jun 18, 2026
30m 43s
Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status
Jun 4, 2026
20m 51s
Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento
May 21, 2026
22m 01s
Multiple Myeloma Care: Timing, Teamwork, Treatment
May 21, 2026
23m 00s
TTP Today: Diagnosis, Management & Evolving Therapies
May 7, 2026
19m 56s
Social Links & Contact
Official channels & resources
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/18/26 | ![]() Unfolding Amyloid: A Patient Perspective | In this episode of Heme Talks, we are joined by Dr. Sai Jambunathan as she shares her experiences with the diagnosis and management of a rare blood disorder known as AL amyloidosis. As a patient herself, listeners will gain insights into the complex initial workup and what the treatment journey is like for patients with this condition. Our patient advocate episodes highlight the importance of advocacy, community, and shared understanding between patients and their healthcare providers. Key Takeaways:AL amyloidosis can present without classic symptoms, making early recognition challenging. Dr. Jambunathan's initial symptoms — fatigue, shortness of breath, and night sweats — were subtle and initially attributed to other causes. Clinicians should maintain a broad index of suspicion, as timely diagnosis significantly impacts prognosis. Clear, compassionate communication from the care team makes a meaningful difference for patients and families. From explaining the diagnosis in accessible language to giving family members direct reassurance, Dr. Jambunathan's experience shows how much patients value providers who take the time to communicate honestly, patiently, and with empathy. Community, advocacy, and peer support are powerful tools for patients navigating a rare disease. Dr. Jambunathan found strength through patient support groups, faith communities, and caregivers — and channeled her experience into advocacy, helping pass an AL amyloidosis awareness month in New Jersey. Organizations like the Amyloidosis Research Consortium offer valuable resources for patients and families seeking connection and information. This podcast episode is supported by Alexion. | 30m 43s | ||||||
| 6/4/26 | ![]() Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status✨ | Absolute Neutrophil CountDuffy Status+4 | Dr. Maureen AchebeDr. Lauren Merz | American Society of Hematology | — | Absolute Neutrophil CountDuffy null variant+5 | — | 20m 51s | |
| 5/21/26 | ![]() Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento✨ | mieloma múltipletratamiento+3 | Dr. DevarakondaKathy Giusti | Multiple Myeloma Research Foundation | — | mieloma múltipletratamiento+4 | — | 22m 01s | |
| 5/21/26 | ![]() Multiple Myeloma Care: Timing, Teamwork, Treatment✨ | multiple myelomatreatment strategies+5 | Dr. DevarakondaKathy Giusti | Multiple Myeloma Research Foundation | — | multiple myelomatreatment+5 | — | 23m 00s | |
| 5/7/26 | ![]() TTP Today: Diagnosis, Management & Evolving Therapies✨ | TTPhematologic emergency+5 | Dr. Yazan Abou-IsmailDr. Kolton Smith | caplacizumabAmerican Society of Hematology+1 | — | TTPdiagnosis+7 | — | 19m 56s | |
| 4/16/26 | ![]() Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring✨ | myelodysplastic neoplasmsdiagnostics+4 | Dr. DeZernDr. Mack | American Society of Hematologymyelodysplastic neoplasms+1 | — | MDSdiagnosis+6 | — | 25m 27s | |
| 3/19/26 | ![]() New Horizons in Smoldering Multiple Myeloma✨ | smoldering multiple myelomatreatment landscape+3 | Brea LipeSagar Lonial | American Society of Hematology | United States | smoldering multiple myelomaMGUS+4 | — | 26m 19s | |
| 2/19/26 | ![]() Interpreting Abnormal SPEP – Is It Just MGUS?✨ | MGUSserum protein electrophoresis+3 | Rahma WarsameJason Chen | American Society of HematologyInterpreting Abnormal SPEP – Is It Just MGUS? | — | MGUSserum monoclonal protein+3 | — | 27m 10s | |
| 1/15/26 | ![]() Sticky Situations: The Role of Thrombophilia Testing in VTE Management✨ | thrombophilia testingVTE management+3 | Ronak MistryJori May | American Society of Hematology | — | thrombophiliaVTE+3 | — | 28m 03s | |
| 12/18/25 | ![]() Lost in Translation: The aHUS Experience✨ | aHUSpatient advocacy+3 | Dr. Toyosi Onwuemene | aHUS FoundationAmerican Society of Hematology | — | aHUShemolytic uremic syndrome+5 | — | 20m 15s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/20/25 | ![]() Inclusion of those with those with Duffy-null Associated Neutrophil Count (DANC) in Clinical Trials✨ | Duffy null phenotypeabsolute neutrophil count+4 | Dr. Andrew HintelDr. Lauren Merz | American Society of HematologyDoris Duke Foundation | — | Duffy-nullneutrophil count+4 | — | 25m 50s | |
| 10/16/25 | ![]() Thalassemia in Pediatric Hematology✨ | thalassemiapediatric hematology+4 | Sujit ShethAshutosh Lal | American Society of Hematologybeta-thalassemia major | MediterraneanMiddle East+2 | thalassemiapediatric+6 | — | 19m 21s | |
| 9/18/25 | ![]() Bridging the Gap: Coordinating CAR-T Care Between Community and Academic Practices✨ | CAR-T therapycare coordination+4 | Dr. CaimiDr. Sdrimas | American Society of Hematology | — | CAR-Tpatient care+6 | — | 20m 00s | |
| 8/21/25 | ![]() Relapsed Myeloma: Navigating Post-BCMA Therapy Failure✨ | relapsed myelomaBCMA therapy failure+4 | Dr. Natalia NeparidzeDr. Saad Z. Usmani | CAR T-cell therapybispecific antibodies+2 | BCMAmultiple myeloma | relapsed myelomaBCMA-targeted therapy+4 | — | 22m 46s | |
| 7/17/25 | ![]() Hereditary Hemorrhagic Telangiectasia: Diagnosis, Management, and Advances✨ | hereditary hemorrhagic telangiectasiadiagnosis+4 | Hanny Al-SamkariAdrienne Hammill | American Society of Hematology | — | HHTtelangiectasia+5 | — | 22m 38s | |
| 6/19/25 | ![]() Thrombotic Microangiopathy in Pregnancy: Challenges and Advances | Join us for an insightful discussion on thrombotic microangiopathy (TMA) in pregnancy with Drs. Richard Burwick and Shruti Chaturvedi as we navigate the complexities of diagnosing and managing hypertensive disorders in pregnancy. These conditions often present overlapping clinical and laboratory features, making timely and accurate intervention challenging. Through the case of a 32-year-old woman at 30 weeks' gestation with severe hypertension, headache, and new-onset thrombocytopenia, we will explore key diagnostic considerations, the distinguishing features of preeclampsia with severe features, Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome, and TMA, and the best strategies for optimizing maternal and fetal outcomes in these high-risk situations. This episode offers practical, evidence-based insights to enhance the recognition and management of pregnancy-related TMA and hypertensive disorders. Learning Objectives: Differentiate between preeclampsia with severe features, HELLP syndrome, and TMA using clinical and laboratory findings. Identify the most appropriate diagnostic tests to confirm the underlying etiology in pregnant patients with hypertension and thrombocytopenia. Discuss immediate and long-term management strategies, including when to initiate delivery and the role of plasma exchange in suspected TMA. | 25m 06s | ||||||
| 5/15/25 | ![]() Unveiling Von Willebrand Disease: Advances in Diagnosis and Treatment | In this episode of HemeTalks, Dr. Jill Johnsen and Dr. Michelle Sholzberg explore Von Willebrand Disease (VWD), the most common inherited bleeding disorder. The discussion delves into the disease's pathophysiology, diagnostic challenges, and the latest advancements in treatment. Learn about the complexities of diagnosing VWD, and discover we are working together to improve outcomes. This episode provides valuable insights for hematologists and healthcare professionals involved in the management of bleeding disorders. Learning Objectives: Understand the different ways that Von Willebrand Disease can present. Identify the challenges and best practices for diagnosing Von Willebrand Disease. Understand treatment options for Von Willebrand Disease and importance of personalized care. | 20m 58s | ||||||
| 4/17/25 | ![]() Battling Invisible Enemies: Toxic Exposures and Hematologic Cancers in Military Members | Join us on HemeTalks as Dr. Christin DeStefano and Dr. Drew Helmer discuss the impact of military toxic exposures on the development of hematologic malignancies, including leukemia, lymphoma, and myeloma. Learn about the challenges of diagnosing and treating these cancers, advancements in research, and strategies for improving care for military members and veterans. Learning Objectives:Discuss challenges in studying the effects of toxic exposures commonly experienced during military service and their links to hematologic cancers. Understand the unique evaluation and treatment challenges for hematologic malignancies in veterans and active-duty military members. Explore hematology-specific research and initiatives aimed at improving early detection and care for this population. | 21m 33s | ||||||
| 3/13/25 | ![]() Iron-Clad Health: Tackling Iron Deficiency in Women | Dr. Anjlee Mahajan (@anjleemd), Dr. Angela Weyand (@acweyand) and Dr. Michelle Sholzberg (@sholzberg ) delve into how current standards of care may contribute to disparities in the diagnosis and treatment of iron deficiency, particularly among female patients, as well as sharing compelling valuable insights into important considerations in addressing and overcoming these challenges to advance quality of care and improved outcomes for patients.Learning Objectives: To educate hematologists and coordinating healthcare providers, where possible, on…Some health inequities and challenges in providing comprehensive care to women with iron deficiency,Examples of identifying and treating patients with iron deficiency, andPractical steps we can all take to improve care of patients with iron deficiency. | 21m 08s | ||||||
| 2/13/25 | ![]() The Road to Inclusion: Navigating Challenges to Haploidentical Donor Transplants | Dr. Shakira Grant and Dr. Irum Kahn explore the fascinating history of stem cell transplants, beginning with its origins and milestones in the field such as the evolution of haploidentical transplants, a groundbreaking approach that has expanded donor options and improved outcomes for patients from diverse backgrounds. They then examine the clinical implications of these advancements, their transformative impact on patient care, and the power of diversity in donation.Learning Objectives: To educate hematologists on…Key barriers patients face in accessing stem cell transplantation, including financial, racial-ethnic, and logistical challenges,The importance of racial and ethnic diversity in stem cell donor registries and the steps being taken to improve it, andPolicy-level solutions and interventions aimed at reducing cost barriers for patients needing stem cell transplantation. | 21m 32s | ||||||
| 1/16/25 | ![]() Blood for All: Clinical Impacts of Diverse Donor Pools | Dr. Rahma Warsame (@RWarsameMD) sits down with Dr. Margo Rollins to explore the critical clinical importance of diverse blood donors and unique challenges faced in recruiting and retaining a diverse donor pool. They then delve into practical strategies and opportunities to overcome these barriers. Join us to gain valuable insights into how enhancing donor diversity can significantly improve patient outcomes and promote health equity. Learning Objectives: To educate hematologists on…The importance of donor diversity in blood donations.Challenges faced in recruiting and retaining a diverse pool particularly from BIPOC communities.Strategies toward overcoming these barriers. | 20m 44s | ||||||
| 12/19/24 | ![]() Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers | Are you a healthcare professional seeking clarity on the evolving treatments for sickle cell disease (SCD)? In this 20-minute episode, experts from cellular therapy and bone marrow transplantation (BMT) explore key updates in SCD care, including curative therapies, gene-editing innovations, and BMT approaches. They address practical challenges in integrating these treatments into practice and discuss strategies to improve access and outcomes. Tune in to discover how collaboration between cellular therapy and BMT providers is transforming care and paving the way for better patient experiences. Learning Objectives Understand recent advancements in curative therapies, including gene editing and BMT, for sickle cell disease. Identify key challenges and barriers to integrating new treatments into clinical practice for SCD patients. Explore collaborative care strategies between cellular therapy and BMT providers to improve patient outcomes and access. | 20m 42s | ||||||
| 11/21/24 | ![]() Inside ASH 2024: Insights from the Education Program Co-Chairs | Join us for an insightful podcast episode featuring the Co-Chairs of the upcoming 2024 ASH Annual Meeting, where we explore the planning process and strategic goals that shaped this year’s program. Discover how the Co-Chairs ensured the Education Program meets the diverse needs of the hematology community, and the unique challenges faced during the planning and how they were overcome. Gain exclusive insights into what makes this event the premier gathering for professionals in the field. Whether attending in person or virtually, find out how you can maximize your experience and apply the latest advancements to your practice or research.Learning Objectives:Understand the Planning Process: Learn about the strategic goals, collaborative efforts, and decision-making that guided the design of the Education Program for the 66th ASH Annual Meeting, ensuring it addresses the diverse needs of the hematology community.Overcome Planning Challenges: Learn about the specific challenges encountered during the planning of this year’s program and how they were effectively managed to deliver a meaningful experience for attendees.Impact on Practice and Research: Understand how this year’s program is designed to impact attendees' practices and research, fostering advancements in the field of hematology. | 16m 06s | ||||||
| 10/24/24 | ![]() Blood Transfusion Safety: TRALI vs TACO | Join us as we explore blood transfusion safety, focusing specifically on Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO). Tailored for general hematologists with a foundational understanding of transfusion medicine, this session delves into the pathophysiology, clinical presentation, diagnostic criteria, and management strategies for TRALI and TACO. Through advanced discussions, participants will deepen their knowledge of these complications, enabling them to recognize, diagnose, and manage TRALI and TACO effectively in clinical practice.Learning Objectives:Gain a thorough understanding of the pathophysiology and clinical presentation of TRALI and TACO.Familiarize with the diagnostic criteria and differential diagnosis of TRALI and TACO.Develop effective management strategies for TRALI and TACO to ensure transfusion safety and enhance patient outcomes. | 20m 03s | ||||||
| 9/12/24 | ![]() Advancing Sickle Cell Disease Care: Navigating Gene Therapy | Are you a hematologist or a generalist provider seeking clarity on how to best counsel patients with sickle cell disease (SCD) who are interested in gene therapy? Join us for a podcast session focused on important patient considerations for gene therapy, tailored for SCD providers and clinicians. This session aims to provide practical insights to facilitate clear communication between providers, patients with SCD, and their families about treatment options.Learning ObjectivesUnderstand the Basics of Gene Therapy Treatments & SCD: By the end of the podcast, listeners will be able to identify some basic tenants of transformative treatments for sickle cell disease (SCD), focusing on how gene therapy treatments compare to other disease modifying treatments.Counseling Patients and Families: Listeners will be given suggestions on what key information to provide to patients and families that are interested in gene therapies, especially considering the build-up to gene therapy and also potential long-term effects.Enhance Communication Skills: This episode will suggest effective communication strategies to provide patients with both perspective and empathy while discussing gene therapy and other treatment options. | 17m 11s | ||||||
Showing 25 of 37
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
29 placements across 28 markets.
Chart Positions
29 placements across 28 markets.

























